| Symbol | IGC |
|---|---|
| Name | IGC PHARMA, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 10224 FALLS ROAD, POTOMAC, Maryland, 20854, United States |
| Telephone | +1 301 983-0998 |
| Fax | — |
| — | |
| Website | https://www.igcinc.us |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001326205 |
| Description | India Globalization Capital Inc is an investment holding company. The companys operating segment includes Infrastructure and Life Sciences. It generates maximum revenue from the Life Sciences segment. The Infrastructure Business segment involves the execution of construction contracts, the rental of heavy construction equipment, and the purchase and resale of physical commodities used in infrastructure. The Life Sciences Segment includes biopharmaceuticals and Over the Counter Products Geographically, it derives a majority of revenue from Hong Kong and also has a presence in India. Additional info from NASDAQ: |
Director PRINS RICHARD K 🟡 adjusted position in 0 shares (2 derivative) of IGC Pharma, Inc. (IGC) Transaction Date: Apr 01, 2026 | Filing ID: 001286
Read moreDirector Mukunda Ram 🟡 adjusted position in 0 shares (4 derivative) of IGC Pharma, Inc. (IGC) at $0.26 Transaction Date: Apr 01, 2026 | Filing ID: 001285
Read moreDirector Moran James P 🟡 adjusted position in 0 shares (2 derivative) of IGC Pharma, Inc. (IGC) Transaction Date: Apr 01, 2026 | Filing ID: 001284
Read moreDirector GRIMALDI CLAUDIA 🟡 adjusted position in 0 shares (2 derivative) of IGC Pharma, Inc. (IGC) at $0.26 Transaction Date: Apr 01, 2026 | Filing ID: 001283
Read more(70% Positive) IGC PHARMA, INC. (IGC) Provides Update on placements for key financial markets
Read moreDirector Mukunda Ram 🟢 acquired 133.3K shares (2 derivative) of IGC Pharma, Inc. (IGC) Transaction Date: Feb 03, 2026 | Filing ID: 000411
Read moreNew Form S-3/A - IGC Pharma, Inc. Filed: 2025-12-03 AccNo: 0001185185-25-001914 Size: 176 KB
Read more